OpsiRx Pharmaceuticals Ltd

Located in Wales, OpsiRx Pharmaceuticals is developing products to treat serious ocular diseases such as uveitis, glaucoma and age-related macular degeneration (AMD). Such diseases are growing in prevalence and incidence. New products are required to combat the increase of such devastating conditions which, if untreated, lead to sight loss. Working with world-leading experts in ophthalmology, OpsiRx is developing products that for unmet medical need in ophthalmology through delivery of products with longer duration of action directly to the eye through minimally invasive needles.